Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study

MLA

Wendy Vaudry, et al. “Congenital Anomalies Following Antenatal Exposure to Dolutegravir: A Canadian Surveillance Study.” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 126, July 2019, pp. 1338–45. EBSCOhost, https://doi.org/10.1111/1471-0528.15838.

APA

Wendy Vaudry, C O’Brien, Ariane Alimenti, Ari Bitnun, Terry C.K. Lee, Fatima Kakkar, Joel Singer, I Boucoiran, Deborah Money, Laura Sauve, & Jason Brophy. (2019). Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study. BJOG: An International Journal of Obstetrics & Gynaecology, 126, 1338–1345. https://doi.org/10.1111/1471-0528.15838

Chicago

Wendy Vaudry, C O’Brien, Ariane Alimenti, Ari Bitnun, Terry C.K. Lee, Fatima Kakkar, Joel Singer, et al. 2019. “Congenital Anomalies Following Antenatal Exposure to Dolutegravir: A Canadian Surveillance Study.” BJOG: An International Journal of Obstetrics & Gynaecology 126 (July): 1338–45. doi:10.1111/1471-0528.15838.